TEMODAL Side Effects

7024555-6 | Retinal Detachment
on Sep 15, 2010 Male patient from SPAIN , 67 years of age, was diagnosed with metastatic malignant melanoma and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: retinal detachment. Temodal dosage: 180 Mg; Po. During the same period patient was treated with NEXAVAR (View Nexavar Review and Nexavar Label ). Patient was hospitalized.

7020469-6 | Convulsion, Fatigue, Memory Impairment, Muscle Spasms, Syncope, Tremor, Vomiting
Patient was taking Temodal (View Usage). Patient had the following side effects: convulsion, fatigue, memory impairment, muscle spasms, syncope, tremor, vomiting on Sep 17, 2010 from AUSTRALIA Additional patient health information: Female patient , 65 years of age, was diagnosed with glioblastoma multiforme and. Temodal dosage: 250 Mg ; 250 Mg. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OSTELIN (View Ostelin Review and Ostelin Label ), CALTRATE (View Caltrate Review and Caltrate Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), NAVOBAN (View Navoban Review and Navoban Label ).

7016508-9 | Deep Vein Thrombosis
Adverse event was reported on Sep 14, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 145 Mg;) was diagnosed with glioblastoma multiforme and. Location: AUSTRALIA , 64 years of age, After Temodal was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), RESPRIM (View Resprim Review and Resprim Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), VALPRO (View Valpro Review and Valpro Label ).

7008753-3 | Pancytopenia
on Sep 15, 2010 Female patient from GREECE , 26 years of age, weighting 187.4 lb, was diagnosed with glioblastoma and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Temodal dosage: 180 Mg; Qd;. During the same period patient was treated with DEXAMETHASOME (View Dexamethasome Review and Dexamethasome Label ), CEDACID (View Cedacid Review and Cedacid Label ).


7007778-1 | Altered State Of Consciousness, B Precursor Type Acute Leukaemia, Cerebral Atrophy, Convulsion, Hydrocephalus, Lymphocyte Count Decreased, Neutrophil Count Decreased, Platelet Count Decreased, Pneumonia
on Sep 13, 2010 Female patient from JAPAN , child 12 years of age, weighting 79.37 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal (View Usage). Patient had the following side effects: altered state of consciousness, b precursor type acute leukaemia, cerebral atrophy, convulsion, hydrocephalus (What is hydrocephalus?), lymphocyte count decreased, neutrophil count decreased, platelet count decreased, pneumonia (What is pneumonia?). Temodal dosage: 75 Mg/m2; Qd; Po, 150 Mg/m2; Qd; Po, 200 Mg/m2; Qd; Po.

7007754-9 | Blood Albumin Decreased, Convulsion, Disorientation, Dyspnoea, Electrolyte Depletion, Feeling Abnormal, Hypocapnia, Hypoxia
Patient was taking Temodal (View Usage). After Temodal was administered, patient had the following side effects: blood albumin decreased, convulsion, disorientation, dyspnoea, electrolyte depletion, feeling abnormal, hypocapnia, hypoxia on Sep 13, 2010 from POLAND Additional patient health information: Female patient , 64 years of age, was diagnosed with glioblastoma multiforme and. Temodal dosage: 140 Mg;, 280 Mg; Qd;, 340 Mg; Qd;.

7007747-1 | B Precursor Type Acute Leukaemia, Cerebral Atrophy, Hydrocephalus, Pneumonia
Adverse event was reported on Sep 13, 2010 by a Female patient taking Temodal (View Usage) (Dosage: 75 Mg/m2; Qd; Po, 150 Mg/m2; Qd; Po, 200 Mg/m2; Qd; Po) was diagnosed with anaplastic astrocytoma and. Location: JAPAN , child 12 years of age, Patient experienced the following unwanted or unexpected effects: b precursor type acute leukaemia, cerebral atrophy, hydrocephalus (What is hydrocephalus?), pneumonia (What is pneumonia?).

7007742-2 | Ascites, Blood Albumin Abnormal, Bone Marrow Failure, Hepatic Function Abnormal, Platelet Count Decreased
on Sep 09, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal (View Usage). Patient had the following side effects: ascites, blood albumin abnormal, bone marrow failure, hepatic function abnormal, platelet count decreased. Temodal dosage: 260 Mg; ; Po. During the same period patient was treated with ZONISAMIDE (View Zonisamide Review and Zonisamide Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), STEROID (View Steroid Review and Steroid Label ), KEISHIKASHAKUYAKUDAIOU TOU (View Keishikashakuyakudaiou-tou Review and Keishikashakuyakudaiou-tou Label ).

7007573-3 | Renal Function Test Abnormal
on Sep 13, 2010 Male patient from JAPAN , 70 years of age, was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: renal function test abnormal. Temodal dosage: 120 Mg; Po.

7007538-1 | Hypertension, Neuropathy Peripheral
Patient was taking Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, neuropathy peripheral on Sep 08, 2010 from FRANCE Additional patient health information: Female patient , 64 years of age, was diagnosed with glioblastoma and. Temodal dosage: Po. During the same period patient was treated with BEVACIZUMAB (BAVECIZUMAB) (660 Mg Iv) (View Bevacizumab (bavecizumab) Review and Bevacizumab (bavecizumab) Label ), IRINOTECAN HCL (220 Mg Iv) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

7007517-4 | Pancytopenia, Septic Shock
Adverse event was reported on Sep 10, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 75 Mg/m2) was diagnosed with glioblastoma multiforme and. Location: AUSTRIA , 71 years of age, Patient had the following side effects: pancytopenia, septic shock. Patient was hospitalized.

7007459-4 | Glioblastoma Multiforme, Interstitial Lung Disease, Malignant Neoplasm Progression, Multi-organ Failure, Pneumocystis Jiroveci Pneumonia
on Sep 10, 2010 Male patient from JAPAN , 65 years of age, weighting 138.9 lb, was diagnosed with glioblastoma multiforme, neoplasm recurrence and was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: glioblastoma multiforme, interstitial lung disease, malignant neoplasm progression, multi-organ failure, pneumocystis jiroveci pneumonia. Temodal dosage: 150 Mg/m2; Qd; Po, 150 Mg/m2;qd;po, 150 Mg/m2;qd;po. During the same period patient was treated with EXCEGRAN (CON.) (View Excegran (con.) Review and Excegran (con.) Label ), DEPAKENE R (CON.) (View Depakene-r (con.) Review and Depakene-r (con.) Label ), MERCAZOLE (CON.) (View Mercazole (con.) Review and Mercazole (con.) Label ).

7007180-2 | Acoustic Neuroma, Leukoencephalopathy, Malignant Neoplasm Progression, Spinal Compression Fracture
on Sep 09, 2010 Female patient from JAPAN , 54 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: acoustic neuroma (What is acoustic neuroma?), leukoencephalopathy, malignant neoplasm progression, spinal compression fracture. Temodal dosage: See Image. Patient was hospitalized.

7007177-2 | Acute Lymphocytic Leukaemia, Bone Marrow Failure, Cerebral Atrophy, Hydrocephalus, Pneumonia
Patient was taking Temodal (View Usage). Patient had the following side effects: acute lymphocytic leukaemia, bone marrow failure, cerebral atrophy, hydrocephalus (What is hydrocephalus?), pneumonia (What is pneumonia?) on Sep 07, 2010 from JAPAN Additional patient health information: Female patient , child 12 years of age, was diagnosed with anaplastic astrocytoma and. Temodal dosage: See Image.

7006669-X | Blood Lactate Dehydrogenase Increased, Cachexia, Decreased Appetite, Gamma-glutamyltransferase Increased, Leukaemia, Neutrophil Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Sep 06, 2010 by a Female patient taking Temodal (View Usage) (Dosage: 75 Mg/m2 Qd Po; 150 Mg/m2 Qd Po; 200 Mg/m2 Po) was diagnosed with anaplastic astrocytoma and. Location: JAPAN , 69 years of age, weighting 116.8 lb, After Temodal was administered, patient had the following side effects: blood lactate dehydrogenase increased, cachexia, decreased appetite, gamma-glutamyltransferase increased, leukaemia, neutrophil count decreased, white blood cell count decreased. During the same period patient was treated with AMLODIN OD (View Amlodin Od Review and Amlodin Od Label ), DEPAS (View Depas Review and Depas Label ).

7006380-5 | Neoplasm Malignant
on Sep 03, 2010 Female patient from CANADA , 68 years of age, was diagnosed with glioblastoma and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: neoplasm malignant. Temodal dosage: 175 Mg; ; Iv. Patient was hospitalized.

7006379-9 | Altered State Of Consciousness, Anaemia, Catheter Site Infection, Cerebral Atrophy, Hypoalbuminaemia, Hypophagia, Oliguria, Oropharyngeal Candidiasis, Platelet Count Decreased
on Sep 03, 2010 Female patient from JAPAN , 74 years of age, weighting 130.3 lb, was diagnosed with anaplastic astrocytoma, cerebral atrophy and was treated with Temodal (View Usage). Patient had the following side effects: altered state of consciousness, anaemia, catheter site infection, cerebral atrophy, hypoalbuminaemia, hypophagia, oliguria, oropharyngeal candidiasis, platelet count decreased. Temodal dosage: 75 Mg/m2; Qd; Po, 150 Mg/m2; Qd; Po, 200 Mg/m2; Qd; Po, 100 Mg/m2; Qd; Po. During the same period patient was treated with BETAMETHASONE (; Po) (View Betamethasone Review and Betamethasone Label ).

6980300-1 | Blood Pressure Increased, Epilepsy, Glioma, Lymphocyte Count Decreased, Neoplasm Progression, Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Temodal (View Usage). After Temodal was administered, patient had the following side effects: blood pressure increased, epilepsy (What is epilepsy?), glioma, lymphocyte count decreased, neoplasm progression, reversible posterior leukoencephalopathy syndrome on Aug 31, 2010 from JAPAN Additional patient health information: Female patient , child 9 years of age, was diagnosed with glioma and. Temodal dosage: ; Po. During the same period patient was treated with AVASTIN (8 Mg/kg;) (View Avastin Review and Avastin Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).

6969291-7 | Hepatitis
Adverse event was reported on Aug 26, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 160 Mg;qd;po) was diagnosed with glioblastoma and. Location: KOREA, REPUBLIC OF , 46 years of age, weighting 132.5 lb, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?).

6969277-2 | Renal Function Test Abnormal
on Aug 26, 2010 Male patient from JAPAN , 70 years of age, was treated with Temodal (View Usage). Patient had the following side effects: renal function test abnormal. Temodal dosage: 120 Mg; Po.

6964092-8 | Anaemia, Aspartate Aminotransferase Increased, Depressed Level Of Consciousness, Haematotoxicity, Hypotension, Klebsiella Sepsis, Lymphopenia, Myocardial Infarction, Neutropenia
on Aug 26, 2010 Female patient from FRANCE , 74 years of age, weighting 152.1 lb, was diagnosed with central nervous system lymphoma and was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: anaemia, aspartate aminotransferase increased, depressed level of consciousness, haematotoxicity, hypotension, klebsiella sepsis, lymphopenia, myocardial infarction, neutropenia. Temodal dosage: 270 Mg;qd;po. During the same period patient was treated with METHOTREXATE (6.3 Gm; Iv) (View Methotrexate Review and Methotrexate Label ), TAHOR (View Tahor Review and Tahor Label ), SECTRAL (View Sectral Review and Sectral Label ), CALCIUM FOLINATE (View Calcium Folinate Review and Calcium Folinate Label ), LASIX (View Lasix Review and Lasix Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6964091-6 | Respiratory Failure
Patient was taking Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory failure on Aug 27, 2010 from GERMANY Additional patient health information: Female patient , 71 years of age, was diagnosed with glioblastoma and. Temodal dosage: 75 Mg;qd;po. Patient was hospitalized.

6964086-2 | Anxiety, Dysgeusia, Malaise, Mouth Ulceration, Neuralgia, Vomiting
Adverse event was reported on Aug 24, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 160 Mg) was diagnosed with glioblastoma and. Location: AUSTRALIA , 56 years of age, Patient had the following side effects: anxiety (What is anxiety?), dysgeusia, malaise, mouth ulceration, neuralgia, vomiting. During the same period patient was treated with PRISTIQ (View Pristiq Review and Pristiq Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6963659-0 | Interstitial Lung Disease, Pneumonia
on Aug 30, 2010 Male patient from JAPAN , 77 years of age, weighting 121.3 lb, was diagnosed with brain neoplasm and was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: interstitial lung disease, pneumonia (What is pneumonia?). Temodal dosage: 120 Mg;qd;po, 240 Mg;qd;po. During the same period patient was treated with GASPORT D (FAMOTIDINE) (View Gasport-d (famotidine) Review and Gasport-d (famotidine) Label ), DIOVAN (View Diovan Review and Diovan Label ), LASIX (View Lasix Review and Lasix Label ), EXCEGRAN (View Excegran Review and Excegran Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6960510-X | Dysgeusia, Mouth Ulceration, Vomiting
on Aug 17, 2010 Male patient from AUSTRALIA , 56 years of age, was diagnosed with glioblastoma and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, mouth ulceration, vomiting. Temodal dosage: 160 Mg;. During the same period patient was treated with PRISTIQ (View Pristiq Review and Pristiq Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6959588-9 | Escherichia Sepsis, Leukoencephalopathy, Staphylococcal Sepsis
Patient was taking Temodal (View Usage). Patient had the following side effects: escherichia sepsis, leukoencephalopathy, staphylococcal sepsis on Aug 24, 2010 from FRANCE Additional patient health information: Female patient , 78 years of age, weighting 156.5 lb, was diagnosed with central nervous system lymphoma and. Temodal dosage: 250 Mg;qd;po. During the same period patient was treated with METHOTREXATE (5900 Mg;qd;iv) (View Methotrexate Review and Methotrexate Label ), SOLU MEDROL (60 Mg;qd;iv) (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (60 Mg;qd;iv) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

6959556-7 | Anaplastic Astrocytoma, Malignant Neoplasm Progression, Oesophageal Candidiasis
Adverse event was reported on Aug 24, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 82.3 Mg/m2;qd;po ; 141 Mg/m2;qd;po ; 141 Mg/m2;qd;po ; 141 Mg/m2;qd;po ; 82.3 Mg/m2;qd;po) was diagnosed with anaplastic astrocytoma and. Location: JAPAN , 54 years of age, weighting 136.7 lb, After Temodal was administered, patient had the following side effects: anaplastic astrocytoma, malignant neoplasm progression, oesophageal candidiasis. During the same period patient was treated with PREDNISOLONE (Po) (View Prednisolone Review and Prednisolone Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6931252-1 | Hepatitis B, Jaundice, Lymphocyte Count Decreased, Malaise
on Aug 09, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with mixed oligo-astrocytoma and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?), jaundice (What is jaundice?), lymphocyte count decreased, malaise. Temodal dosage: 100 Mg;po. During the same period patient was treated with FERON (View Feron Review and Feron Label ).

6929546-9 | Cerebral Infarction, Platelet Count Decreased, Pneumocystis Jiroveci Pneumonia
on Aug 10, 2010 Male patient from JAPAN , 73 years of age, weighting 132.3 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal (View Usage). Patient had the following side effects: cerebral infarction, platelet count decreased, pneumocystis jiroveci pneumonia. Temodal dosage: 100 Mg; Qd; Po. During the same period patient was treated with NAUZELIN (View Nauzelin Review and Nauzelin Label ), EXCEGRAN (View Excegran Review and Excegran Label ), HERBESSER (View Herbesser Review and Herbesser Label ), EPADEL (View Epadel Review and Epadel Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), MOBIC (View Mobic Review and Mobic Label ), GASTER (View Gaster Review and Gaster Label ), BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ). Patient was hospitalized.

6926208-9 | Headache, Nausea, Pulmonary Embolism, Pyrexia
Patient was taking Temodal (View Usage). After Temodal was administered, patient had the following side effects: headache (What is headache?), nausea (What is nausea?), pulmonary embolism (What is pulmonary embolism?), pyrexia on Aug 05, 2010 from FINLAND Additional patient health information: Male patient , 61 years of age, was diagnosed with glioblastoma multiforme and. Temodal dosage: 75 Mg/m2;. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ).

6925534-7 | Intestinal Perforation
Adverse event was reported on Aug 04, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 50 Mg/m2;po, 150 Mg/m2; Po) was diagnosed with glioblastoma and. Location: GERMANY , 65 years of age, Patient experienced the following unwanted or unexpected effects: intestinal perforation. During the same period patient was treated with INDOMETHACIN (25 Mg;bid, 25 Mg;bid) (View Indomethacin Review and Indomethacin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6925503-7 | Hepatitis, Thrombocytopenia
on Aug 04, 2010 Male patient from GERMANY , 58 years of age, was diagnosed with glioblastoma and was treated with Temodal (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), thrombocytopenia. Temodal dosage: 150 Mg/m2; Po, 50 Mg/m2; Po. During the same period patient was treated with INDOMETHACIN (25 Mg;bid) (View Indomethacin Review and Indomethacin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), TROPISETRON (View Tropisetron Review and Tropisetron Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6925464-0 | Gastroenteritis, Renal Failure Acute, Sepsis, Subileus
on Aug 04, 2010 Male patient from GERMANY , 40 years of age, was diagnosed with glioblastoma and was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: gastroenteritis (What is gastroenteritis?), renal failure acute, sepsis (What is sepsis?), subileus. Temodal dosage: 50 Mg/m2. During the same period patient was treated with INDOMETHACIN (25 Mg; Bid;) (View Indomethacin Review and Indomethacin Label ), TROPISETRON (View Tropisetron Review and Tropisetron Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6924466-8 | Pneumonia Cytomegaloviral, Respiratory Failure
Patient was taking Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia cytomegaloviral, respiratory failure on Aug 04, 2010 from GERMANY Additional patient health information: Female patient , 49 years of age, was diagnosed with glioblastoma and. Temodal dosage: 150 Mg/m2 Po; 75 Mg/m2 Po; 150 Mg/m2 Po. During the same period patient was treated with INDOMETHACIN (25 Mg Bid) (View Indomethacin Review and Indomethacin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), QUETIAPIN (View Quetiapin Review and Quetiapin Label ).

6920198-0 | Tumour Haemorrhage
Adverse event was reported on Aug 04, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 50 Mg/m2) was diagnosed with glioblastoma and. Location: GERMANY , 66 years of age, Patient had the following side effects: tumour haemorrhage. During the same period patient was treated with INDOMETHACIN (25 Mg;bid) (View Indomethacin Review and Indomethacin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), TRIMETHOPRIM/SULFAMETHOXAZOL (View Trimethoprim/sulfamethoxazol Review and Trimethoprim/sulfamethoxazol Label ). Patient was hospitalized.

6913442-7 | Fall, Nervous System Disorder
on Jul 26, 2010 Male patient from SPAIN , 54 years of age, was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: fall (What is fall?), nervous system disorder. Temodal dosage: . During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6907339-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Convulsion, Gamma-glutamyltransferase Increased, Glioblastoma Multiforme, Hepatic Function Abnormal, Malignant Neoplasm Progression
on Jul 29, 2010 Female patient from JAPAN , 66 years of age, weighting 105.8 lb, was diagnosed with glioblastoma multiforme, neoplasm recurrence, epilepsy (What is epilepsy?) and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, convulsion, gamma-glutamyltransferase increased, glioblastoma multiforme, hepatic function abnormal, malignant neoplasm progression. Temodal dosage: 150 Mg/m2;qd;po. During the same period patient was treated with DEPAKENE (;po) (View Depakene Review and Depakene Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), GASTER (View Gaster Review and Gaster Label ), PURSENNID (View Pursennid Review and Pursennid Label ), MAGMITT (View Magmitt Review and Magmitt Label ).

6897134-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Brain Oedema, Gamma-glutamyltransferase, Gamma-glutamyltransferase Increased, Somnolence
Patient was taking Temodal (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, brain oedema, gamma-glutamyltransferase, gamma-glutamyltransferase increased, somnolence on Jul 22, 2010 from AUSTRIA Additional patient health information: Male patient , 47 years of age, weighting 207.2 lb, was diagnosed with glioblastoma and. Temodal dosage: 315 Mg; ; Po. Patient was hospitalized.

6888050-7 | Neoplasm Recurrence
Adverse event was reported on Jul 20, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 75 Mg/m2;qd;po 150 Mg/m2;qd/po) was diagnosed with glioblastoma multiforme and. Location: JAPAN , 72 years of age, weighting 112.9 lb, After Temodal was administered, patient had the following side effects: neoplasm recurrence. During the same period patient was treated with NITOROL R (View Nitorol R Review and Nitorol R Label ), RINDERON (View Rinderon Review and Rinderon Label ).

6888049-0 | Anaplastic Astrocytoma, Lymphocyte Count Decreased, Malignant Neoplasm Progression, Metastases To Central Nervous System, Pneumonia Aspiration
on Jul 20, 2010 Male patient from JAPAN , 67 years of age, weighting 158.7 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: anaplastic astrocytoma, lymphocyte count decreased, malignant neoplasm progression, metastases to central nervous system, pneumonia aspiration. Temodal dosage: 150 Mg/m2;qd;po 200 Mg/m2;qd;po. During the same period patient was treated with GASTER D (View Gaster D Review and Gaster D Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OPSO (View Opso Review and Opso Label ), MOBIC (View Mobic Review and Mobic Label ), LAC B (BIFIDOBACTERIUM) (View Lac-b (bifidobacterium) Review and Lac-b (bifidobacterium) Label ).

6875907-6 | Acute Myocardial Infarction, Cardiac Failure, Central Nervous System Lymphoma, Hypokalaemia, Malignant Neoplasm Progression, Status Epilepticus
on Jul 21, 2010 Female patient from FRANCE , 81 years of age, weighting 158.7 lb, was diagnosed with central nervous system lymphoma and was treated with Temodal (View Usage). Patient had the following side effects: acute myocardial infarction, cardiac failure, central nervous system lymphoma, hypokalaemia, malignant neoplasm progression, status epilepticus. Temodal dosage: 280 Mg;qd. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6862691-5 | Febrile Bone Marrow Aplasia, Haemoglobin Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Temodal (View Usage). After Temodal was administered, patient had the following side effects: febrile bone marrow aplasia, haemoglobin decreased, platelet count decreased, white blood cell count decreased on Jul 12, 2010 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with malignant melanoma and. Temodal dosage: 200 Mg/m2;qd;po, 100 Mg/m2;qd;po, 150 Mg/m2;qd;po. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), SOTALEX (View Sotalex Review and Sotalex Label ), NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), LOVENOX (View Lovenox Review and Lovenox Label ).

6861360-5 | Bone Marrow Failure, Disease Progression, Glioblastoma Multiforme, Pneumonia Bacterial, Post Procedural Infection
Adverse event was reported on Jul 13, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 150 Mg/m2;qd;po, 200 Mg/m2;qd;po, 150 Mg/m2;qd;po) was diagnosed with glioblastoma multiforme and. Location: JAPAN , 52 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, disease progression, glioblastoma multiforme, pneumonia bacterial, post procedural infection. During the same period patient was treated with AMOXAN (View Amoxan Review and Amoxan Label ), ISALON (View Isalon Review and Isalon Label ), MYSTAN (View Mystan Review and Mystan Label ), DEPAKENE (View Depakene Review and Depakene Label ), PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6860943-6 | Ataxia, Bladder Disorder, Brain Stem Ischaemia, Cerebral Ischaemia, Coordination Abnormal, Encephalitis Herpes, Hemiparesis, Hypoglossal Nerve Paralysis, Iiird Nerve Paralysis
on Jul 12, 2010 Female patient from LATVIA , weighting 163.1 lb, was treated with Temodal (View Usage). Patient had the following side effects: ataxia (What is ataxia?), bladder disorder, brain stem ischaemia, cerebral ischaemia, coordination abnormal, encephalitis herpes, hemiparesis, hypoglossal nerve paralysis, iiird nerve paralysis. Temodal dosage: Po, 185 Mg; Qd; Po. Patient was hospitalized and became disabled.

6846955-7 | Cholangitis, Convulsion, Cytolytic Hepatitis, Glioblastoma, Hepatitis Cholestatic, Jaundice, Neoplasm Recurrence, Ocular Icterus
on Jul 08, 2010 Male patient from FRANCE , 64 years of age, was diagnosed with glioma, epilepsy (What is epilepsy?), herpes virus infection, paraesthesia and was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: cholangitis, convulsion, cytolytic hepatitis, glioblastoma, hepatitis cholestatic, jaundice (What is jaundice?), neoplasm recurrence, ocular icterus. Temodal dosage: 145 Mg; Qd; Po. During the same period patient was treated with KEPPRA (750 Mg; Bid; Po) (View Keppra Review and Keppra Label ), VALACYCLOVIR (1000 Mg; Bid; Po) (View Valacyclovir Review and Valacyclovir Label ), URBANYL (CLOBAZAM) (10 Mg; Qd; Po) (View Urbanyl (clobazam) Review and Urbanyl (clobazam) Label ), NEXIUM (View Nexium Review and Nexium Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6846954-5 | Kaposi's Sarcoma, Skin Discolouration, Skin Lesion
Patient was taking Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: kaposi's sarcoma (What is kaposi's sarcoma?), skin discolouration, skin lesion on Jul 08, 2010 from GREECE Additional patient health information: Male patient , 63 years of age, was diagnosed with glioblastoma multiforme and. Temodal dosage: 150 Mg/m2, 200 Mg/m2. Patient was hospitalized.

6843465-8 | Pulmonary Embolism
Adverse event was reported on Jul 08, 2010 by a Male patient taking Temodal (View Usage) (Dosage: 75 Mg/m2; Qd; Po 150 Mg/m2; Qd; Po) was diagnosed with glioblastoma multiforme and. Location: JAPAN , 72 years of age, weighting 125.7 lb, Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with RINDERON (BETAMETHASONE) (BETAMETHASONE /00008501/) (;po) (View Rinderon (betamethasone) (betamethasone /00008501/) Review and Rinderon (betamethasone) (betamethasone /00008501/) Label ), COTRIM (View Cotrim Review and Cotrim Label ), ZOFRAN (View Zofran Review and Zofran Label ), PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ). Patient was hospitalized.

6842233-0 | Acute Myocardial Infarction, Cardiac Failure, Hypokalaemia, Lung Infection, Lymphoma, Malignant Neoplasm Progression, Status Epilepticus, Urinary Tract Infection
on Jul 05, 2010 Female patient from FRANCE , 81 years of age, weighting 158.7 lb, was diagnosed with central nervous system lymphoma and was treated with Temodal (View Usage). After Temodal was administered, patient had the following side effects: acute myocardial infarction, cardiac failure, hypokalaemia, lung infection, lymphoma (What is lymphoma?), malignant neoplasm progression, status epilepticus, urinary tract infection (What is urinary tract infection?). Temodal dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6831658-5 | Febrile Bone Marrow Aplasia, Haematoma
on Jun 29, 2010 Male patient from FRANCE , 79 years of age, was diagnosed with malignant melanoma and was treated with Temodal (View Usage). Patient experienced the following unwanted or unexpected effects: febrile bone marrow aplasia, haematoma. Temodal dosage: 200 Mg/m2;qd;po, 100 Mg/m2;qd;po, 150 Mg/m2;qd;po. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), SOTALEX (View Sotalex Review and Sotalex Label ), NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), LOVENOX (View Lovenox Review and Lovenox Label ).

6831651-2 | Bone Marrow Failure, Pyrexia
Patient was taking Temodal (View Usage). Patient had the following side effects: bone marrow failure, pyrexia on Jun 30, 2010 from FRANCE Additional patient health information: Female patient , 42 years of age, weighting 183.0 lb, was diagnosed with glioblastoma and. Temodal dosage: 140 Mg;qd;po. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), SOLUPRED (View Solupred Review and Solupred Label ), NEXIUM (View Nexium Review and Nexium Label ), TENORMIN (View Tenormin Review and Tenormin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), LASIX (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ).